Maa: Australia
Kieli: englanti
Lähde: Department of Health (Therapeutic Goods Administration)
cefoxitin sodium, Quantity: 1.051 g
Juno Pharmaceuticals Pty Ltd
cefoxitin sodium
Injection, powder for
Excipient Ingredients:
Intramuscular, Intravenous
10 x 1g vials, 5 x 1g vial
(S4) Prescription Only Medicine
Cefoxitin Sodium for Injection is indicated for the treatment of the following infections when due to susceptible organisms (see Microbiology): peritonitis and other intra-abdominal and intra-pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, and skin and skin structure infections. Cefoxitin Sodium for Injection has a high degree of stability against beta-lactamase and therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. It can also be used in mixed infections provided that the organisms are sensitive to it. Cefoxitin Sodium can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscus perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes or anaerobes. Cefoxitin Sodium for Injection is also indicated for the prevention of post-operative infections associated with certain surgical procedures of the gastrointestinal, biliary and genital tracts.
Visual Identification: A white to slightly yellow powder; Container Type: Vial; Container Material: Glass Type III Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
1994-10-14
Page 1 CEFOXITIN JUNO Cefoxitin Sodium (ke-FOX-it-in _)_ _ _ _ _ CONSUMER MEDICINE INFORMATION _Date of Dispensing _ _Consumer Name _ _Pharmacist Name_ _Consumer Address _ _Pharmacist Address_ _ _ _ _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Cefoxitin Juno. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given cefoxitin against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT CEFOXITIN JUNO IS USED FOR Cefoxitin is an antibiotic that belongs to a group of medicines called cephalosporins. It is used to treat many different types of infections caused by bacteria. It works by killing the bacteria responsible for your infection. It may be given with other antibiotics. It will not work against infections caused by viruses such as colds or the flu. Your doctor may have prescribed cefoxitin for another reason. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY CEFOXITIN HAS BEEN PRESCRIBED FOR YOU. This medicine is available only with a doctor’s prescription. Cefoxitin is not addictive BEFORE YOU ARE GIVEN CEFOXITIN JUNO _WHEN YOU MUST NOT BE _ _GIVEN IT_ _ _ CEFOXITIN JUNO IF YOU HAVE AN ALLERGY TO: • any medicine containing Cefoxitin • any other cephalosporin antibiotics. Some of the symptoms of an allergic reaction may include: • shortness of breath, wheezing or difficulty breathing; • swelling of the face, lips, tongue or other parts of the body; • rash, itching or hives on the skin. YOU MUST NOT BE GIVEN THIS MEDICINE IF YOU HAVE HAD A SERIOUS ALLERGIC REACTION TO PENICILLIN ANTIBIOTICS. CEFOXITIN SHOULD NOT BE MIXED WITH LIGNOCAINE AND GIVEN TO YOU IF YOU HAVE HAD AN ALLERGIC REACTION TO LIGNOCAINE. SOMETIMES CEFOXITIN JUNO IS MIXED WITH LIGNOCAINE HYDROCHLORIDE SO THAT THE IN Lue koko asiakirja
Juno Pharmaceuticals Pty Ltd Australian Product Information Page | 1 AUSTRALIAN PRODUCT INFORMATION CEFOXITIN JUNO _(CEFOXITIN SODIUM) _ _ _ 1 NAME OF THE MEDICINE Cefoxitin sodium 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram of cefoxitin sodium contains approximately 51.2 mg (2.2 mEq) of sodium. The pH of 10% w/v cefoxitin sodium in Water for Injections is 4.2 to 7.0. Each Vial contains cefoxitin sodium equivalent to 1g or 2g of cefoxitin. 3 PHARMACEUTICAL FORM Cefoxitin Juno powder for Injection is a white to slightly yellow sterile powder of cefoxitin sodium for intravenous and intramuscular administration following reconstitution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Cefoxitin (as sodium) Powder for Injection is indicated for the treatment of the following infections when due to susceptible organisms (see SECTION 5.1 PHARMACODYNAMIC PROPERTIES - MICROBIOLOGY) peritonitis and other intra-abdominal and intra- pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, skin and skin structure infections. Cefoxitin (as sodium) Powder for Injection has a high degree of stability against beta- lactamase and is therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. It can also be used in mixed infections provided that the organisms are sensitive to it. Cefoxitin (as sodium) Powder for Injection can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscus perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes, or anaerobes. Cefoxitin (as sodium) Powder for Injection is also indicated for the prevention of post operative infections associated with certain surgical procedures of the gastrointestinal, biliary and genital tracts. 4.2 DOSE AND METHOD OF ADMINISTRATION TREATMENT Cefoxitin Juno Powder for Injectio Lue koko asiakirja